Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA ≥ 99.9.

Highly sensitized patients (especially those with a calculated Panel Reactive Antibody ≥ 99.9%) have little to no chances of having access to transplantation. Recently, delisting of human leukocyte antigens has been proposed as a possible strategy to…

Preview only. Read the full abstract at the source